1-6 of 6
Kanda Sangthongpitag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Specific Inhibitors Of The BCR-ABL and MNK Kinases As Potential Therapeutics For Blast Crisis Chronic Myeloid Leukemia

Sharon Lim, Joseph Cherian, Kassoum Nacro, Yun Shan Chew, Meng Ling Choong, Jun Ding Li, Samantha Guo, Melvyn Ho, Joma Joy, Perlyn Kwek, May Ann Lee, Boping Liu, Vithya Manoharan, Esther Ong, Vishal Pendharkar, Zhi Ying Poh, Anders Poulsen, Kanda Sangthongpitag, Kannan Srinivararaghavan, Siew Peng Tan, Haiyan Yang, Thomas H. Keller, Charles Chuah, MD, S. Tiong Ong, Jeffrey Hill, Alex Matter
Journal: Blood
Blood (2013) 122 (21): 2702.
https://doi.org/10.1182/blood.V122.21.2702.2702
Published: 2013
Journal Articles

Combination Treatment with JAK2 and PI3K Inhibitors in Myeloproliferative Neoplasms

Meng Ling Choong, PhD, Christian Pecquet, PhD, Shi Jing Tai, Jacklyn WY Yong, PhD, Vishal Pendharkar, SiFang Wang, Jean-Philippe Defour, BPharm, Carmen C. Diaconu, PhD, Kanda Sangthongpitag, PhD, Jean-Luc Villeval, PhD, William Vainchenker, MD, PhD, Stefan N. Constantinescu, MD, PhD, May Ann Lee, PhD
Journal: Blood
Blood (2012) 120 (21): 180.
https://doi.org/10.1182/blood.V120.21.180.180
Published: 2012
Journal Articles

SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.

Kee C. Goh, Wai C. Ong, Changyong Hu, Hannes Hentze, Ai L. Liang, Walter Stunkel, Yong C. Tan, Kanda Sangthongpitag, Siok K. Goh, Shirly Sieh, Zahid Q. Bonday, Anthony D. William, Angeline Lee, Stephanie Blanchard, Te C. Liu, Martin Sattler, James D. Griffin, Brian W. Dymock, Ethirajulu Kantharaj, Jeanette M. Wood
Journal: Blood
Blood (2007) 110 (11): 538.
https://doi.org/10.1182/blood.V110.11.538.538
Published: 2007
Journal Articles

Pharmacokinetic and Pharmacodynamic Properties of SB1317, a Potent and Orally Active Multi-Kinase Inhibitor.

Pauline Yeo, P. Venkatesh, Evelyn Goh, Peizi Zeng, Lee S. New, Changyong Hu, Kanda Sangthongpitag, Anthony D. William, Kee C. Goh, Jeanette M. Wood, Ethirajulu Kantharaj
Journal: Blood
Blood (2007) 110 (11): 4201.
https://doi.org/10.1182/blood.V110.11.4201.4201
Published: 2007
Journal Articles

SB1317, a Potent and Orally Active FLT3-CDK Inhibitor with High Anti-Tumor Efficacy in Models of Hematological Malignancies.

Kee C. Goh, PhD, Wai C. Ong, BSc, Changyong Hu, MD, PhD, Ai L. Liang, BSc, Walter Stunkel, PhD, Yong C. Tan, MSc, Kanda Sangthongpitag, PhD, Siok K. Goh, BSc, Zahid Q. Bonday, PhD, Anthony D. William, PhD, Brian W. Dymock, PhD, Ethirajulu Kantharaj, PhD, Jeanette M. Wood, PhD
Journal: Blood
Blood (2007) 110 (11): 1593.
https://doi.org/10.1182/blood.V110.11.1593.1593
Published: 2007
Journal Articles

SB939: A Potent and Orally Active HDAC Inhibitor for the Treatment of Hematological Malignancies.

Kanda Sangthongpitag, Walter Stunkel, Zahid Q. Bonday, Kee C. Goh, Xukun Wang, Xiaofeng Wu, Changyong Hu, Haishan Wang, Niefang Yu, Eric Sun, Michael Entzeroth, Ethirajulu Kantharaj, Chien-Shing Chen, Jeanette M. Wood
Journal: Blood
Blood (2007) 110 (11): 1603.
https://doi.org/10.1182/blood.V110.11.1603.1603
Published: 2007